Locoregional Therapy of Hepatocellular Carcinoma
Authors:
- 12 March 2015
- journal article
- review article
- Published by Elsevier in Clinics in Liver Disease
- Vol. 19 (2) , 401-420
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- Evaluation of intraoperative microwave coagulo‐necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive casesJournal of Hepato-Biliary-Pancreatic Sciences, 2012
- Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beadsJournal of Hepatology, 2012
- Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical RecommendationsCardioVascular and Interventional Radiology, 2011
- Management of Hepatocellular Carcinoma: An Update ΔσHepatology, 2011
- Radioembolization Results in Longer Time-to-Progression and Reduced Toxicity Compared With Chemoembolization in Patients With Hepatocellular CarcinomaGastroenterology, 2011
- Imaging Response in the Primary Index Lesion and Clinical Outcomes Following Transarterial Locoregional Therapy for Hepatocellular CarcinomaJAMA, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Liver Regeneration and the Atrophy-Hypertrophy ComplexSeminars in Interventional Radiology, 2008
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002